Longevity
SS-20
per administration
Only animal or lab studies exist — no human study has set an amount.
Quick start
SS-20 at a glance — the figures, plus how it's commonly run. Reference only, not medical advice.
- Typical dose
- 1–5 mg per administration
- How often
- Every day
- Where
- Commonly subcutaneous Sites and rotation
- Time to steady level
- ~10 hours — about five half-lives
- Storage
- Dry vial kept cold and dark; a mixed vial in the fridge at 2–8 °C. Details
A research and community reference, not medical advice. Figures are descriptive, vary between sources, and are not a recommendation for use.
Work out your draw
These numbers are a starting point — change any of them.
Vial label
Copy this into your label printer.
Published research contexts for SS-20 describe 1–5 mg per administration. Descriptive only, not a recommendation.
Not characterized in humans; assumed similar to the related Szeto–Schiller peptides, so read as order-of-magnitude only.
A Szeto–Schiller mitochondrial-targeted peptide related to SS-31 (elamipretide); evidence is preclinical and no human study fixes an amount or schedule, so the figures are not trial-established and no schedule table is shown.
Modelled level — every day
1× is the peak after a single dose.
- Steady-state peak
- 1.00× single dose
- Time to steady state
- 10hours
- Administrations
- 7/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- Szeto–Schiller peptide preclinical literatureSS-20 is characterized in animal and cell models of mitochondrial function; human dosing is not established.